Daily Judi: Thursday, September 15, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Cambridge, Massachusetts-based biotech, Third Harmonic Bio, sold 10.9 million shares in the largest initial public offering for the sector in almost six months, raising $185 million. (BioPharma Dive)
Stat examines the many startups with designs on improving diversity in clinical trials, interviewing one researcher who named it a “modern-day gold rush.”
Yahoo Finance reports clinical trials are expected to be a $52 billion market by 2026, increasing over $14 billion from 2021.
Meanwhile, Nikkei Asia reports that China is making moves to use only internally produced medical equipment.
The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team Judi will be there!
Our Culture
“We are small enough that we are nimble, so we can prioritize quickly, yet also of significant size that we allocate resources where needed. We truly do a lot. This is my dream job. Judi allows me to have a bigger impact. And we do great work.”
–Jess, Program Manager
About Judi
Judi empowers and enhances the world's clinical trial ecosystems. Our cloud-based platform has 110,000 users across 140 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.
